Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Should you buy SLV the silver ETF?

Charts presented in this report are courtesy Stockcharts.com. Featured is the daily bar chart for SLV. Price has risen for five days, but volume has not yet supported the rise. This lack of volume could be because more and more people are becoming aware of the f...
Peter Degraaf | October 28, 2012 |

Morning Market Outlook for Nov. 21, 2023

Stephen Whiteside of TheUpTrend.com gives us an early look at the markets, examines tech darling NVIDIA, compares opportunities and more in the Morning Market Outlook for Tuesday. Navigate the dynamic world of market moves effortlessly and stay ahead of the game with da...
TheUpTrend | November 21, 2023 |

New Gold & Silver Bull Analogs

Back during the bear market years (it’s nice to be able to write that now), I regularly would compare the declines in Gold, Silver and gold stocks to their past history. It gave us a visual representation of just how bad the forever bear market was and helped u...
Jordan Roy-Byrne, CMT | August 27, 2019 |

Best Canadian Stocks

When it comes to investing in Canadian companies, bigger is not always better. Canada’s historic corporate giants – energy and material sectors, such as the forestry industry – have had a difficult time over the past few years due to macroeconomic condition...
Stockhouse Editorial | June 4, 2019 |

Seabed rare earth and precious metal mining

Rising prices in precious metals and China’s monopoly in rare earth elements are leading to creativity and innovation in mining. For instance, Japan reported last month that they found extremely rich deposits of rare earth minerals on the seabed of the Pa...
Justin Dove | October 28, 2012 |

Is 2019 Similar to 2007? What Does It Mean For Gold?

The Fed cut the interest rates at the end of July. As the previous easing cycle started in September 2007, many analysts are saying that the current year looks more and more like 2007. We invite you to read our today’s article that compares the current year w...
Arkadiusz Sieron | September 12, 2019 |

How IoT is Disrupting Mining in a Major Way

Be long the disruptors, and short the disrupted. It's one of the biggest themes in the investment world over the past 10 years. You know you could have bought Netflix stock in 2002 for $1.07 per share? Today shares are worth over $320 per shar...
Marin Katusa | August 7, 2019 |

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. Biopharmaceutical company Puma Biotechnology Inc. (PBYI:NADSAQ) shares opened more than 20% higher to...
Streetwise Reports | August 14, 2019 |

'Outsized Dislocation' of Wind Blade Maker's Stock Means Buying Opportunity: Analyst

A disconnect surrounding the company's EBITDA multiple is discussed in a Raymond James report. In an Aug. 20 research note, analyst Pavel Molchanov reported that Raymond James upgraded its recommendation on TPI Composites Inc. (TPIC:NASDAQ) to Strong Buy from Outper...
Streetwise Reports | August 28, 2019 |

Topline Results from Lipid-Lowering Trial 'Just What the Doctor Ordered'

The study data and their implications are provided in a BTIG report. In an Aug. 29 research note, BTIG analyst Thomas Shrader reported that just released topline data are "as hoped" from Esperion Therapeutics Inc.'s (ESPR:NASDAQ) Phase 2 trial of bempedoic acid-ezet...
Streetwise Reports | September 5, 2019 |
1 2 3 4 5 6 7